IntrinsicIntrinsic
← Scroll for more →

Financial Statements — SPRB

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents96.3054.0848.9110.6716.3925.6238.7560.0669.6881.1596.3498.8097.4873.9324.4921.6547.2123.3442.7558.36
Short-term Investments--------------------0.009.2323.0444.6654.5968.7546.0968.0146.2233.96
Accounts Receivable--------------------------15.00------------
Total Current Assets101.1555.0352.1114.5220.9530.5844.2163.5773.9185.87102.18111.14124.13137.2483.6193.1996.5195.1091.9093.92
Property, Plant & Equipment--------------------------------0.130.130.14--
Total Non-current Assets*1.701.130.910.800.871.071.001.531.611.671.761.851.831.882.042.118.0119.8934.5941.17
Total Assets102.8556.1753.0215.3121.8231.6545.2165.1075.5287.54103.95112.99125.96139.1185.6595.30104.52114.99126.49135.09
Accounts Payable1.212.680.941.390.811.881.301.800.681.893.333.150.953.451.432.181.451.112.822.13
Total Current Liabilities10.9611.7810.099.438.0615.6715.2511.8614.2918.3924.4724.1922.7323.0012.4512.0010.108.978.879.06
Long-term Debt19.9420.410.000.550.971.401.842.302.763.233.714.204.685.175.645.624.894.894.884.87
Total Non-current Liabilities*8.169.730.420.500.580.661.141.612.072.522.973.426.678.124.724.825.295.786.246.31
Total Liabilities19.1221.5210.519.938.6416.3316.3913.4616.3520.9227.4427.6029.4031.1217.1616.8215.3914.7515.1215.37
Retained Earnings(317.73)(301.50)(289.23)(274.59)(266.38)(264.31)(250.27)(226.71)(218.04)(208.86)(197.23)(187.28)(174.93)(162.10)(149.31)(138.17)(126.77)(114.89)(103.13)(93.95)
Total Stockholder Equity83.7334.6542.525.3913.1815.3228.8251.6459.1766.6276.5185.3896.56108.0068.4978.4789.12100.24111.37119.72
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue----0.000.000.000.000.700.601.612.002.893.072.171.96------------
Research & Development12.167.584.105.01(0.43)10.8421.466.558.0910.3211.1013.4913.1311.718.848.799.068.516.268.61
Selling, General & Admin4.354.417.003.223.123.663.313.463.564.322.953.243.013.453.272.772.823.232.882.79
Total Operating Expenses16.5111.9911.108.232.6914.4924.7710.0111.6514.6414.0516.7316.1415.1612.1111.5611.8811.739.1411.40
Operating Income(16.51)(11.99)(11.10)(8.23)(2.69)(14.49)(24.07)(9.41)(10.04)(12.63)(11.16)(13.66)(13.97)(13.20)(12.11)(11.56)(11.88)(11.73)(9.13)(11.40)
Interest Expense1.100.670.010.020.030.040.060.070.080.100.110.120.130.130.130.110.090.090.090.09
Net Income(16.23)(12.27)(14.65)(8.21)(2.07)(14.04)(23.56)(8.67)(9.18)(11.62)(9.95)(12.35)(12.82)(12.79)(11.14)(11.40)(11.87)(11.76)(9.18)(11.45)
Basic EPS(6.68)(8.94)(32.43)(14.58)(3.50)(0.32)(0.58)(0.21)(0.22)(0.28)(0.22)(0.30)(0.32)(0.40)(0.47)(0.48)--------
Diluted EPS(6.68)(8.94)(32.43)(14.58)(3.50)(0.32)(0.58)(0.21)(0.22)(0.28)(0.22)(0.30)(0.32)(0.40)(0.47)(0.48)--------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(22.12)(8.73)(6.46)(5.32)(8.83)(12.73)(20.68)(9.22)(11.11)(14.96)(11.21)(12.27)1.99(11.79)(11.74)(8.58)(9.54)(11.83)(9.80)(7.60)
Capital Expenditures0.140.01--------0.000.00----0.000.010.00--0.000.000.01--0.010.07
Free Cash Flow*(22.25)(8.74)--------(20.68)(9.22)----(11.21)(12.28)1.99--(11.74)(8.58)(9.55)--(9.80)(7.66)
Investing Cash Flow(0.13)(0.01)--------0.000.000.000.009.3013.9922.0010.4814.57(16.89)33.51(7.49)(5.98)(12.33)
Financing Cash Flow64.4713.9244.69(0.40)(0.40)(0.41)(0.62)(0.40)(0.36)(0.23)(0.55)(0.40)(0.43)50.530.04(0.09)(0.10)(0.09)0.170.02
← Scroll for more columns →

* Derived from reported values